SL
Sellas Life Sciences Group Inc
🇩🇪XFRA.RXK3GermanyHealthcare
€10.20EURdown -0.30 (-2.86%)OpenEnd of day7:52 PM
Price€10.20-0.30 (-2.86%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- US81642T2096
- CUSIP
- Not reported
Company
- Employees
- 13
- Headquarters
- New York, United States
- CEO
- Dr. Angelos M. Stergiou M.D., ScD h.c.
Market
- Shares outstanding
- 142.4M
- Market cap
- €1.45B
Highlights
No high and low reported for today's session.
- Market cap
- €1.45B
- EPS LTM
- -$0.23calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- Not reported
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $00%unchanged year on year
- Net income
- -$32.46M-23.62%down year on year
- Gross margin
- Not reported
- Free cash flow
- -$28.42M+9.36%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.